Cardiac Dimensions Stock

cardiacdimensions.comHealthcare / BioTech & PharmaFounded: 2001

Cardiac Dimensions is a private biotech firm that specializes in device treatments for cardiac failure, functional mitral regurgitation (FMR), and other structural diseases of the heart. The company has developed a new device called Carillon Therapy, a system of wiring that is placed non-invasively into the heart muscle next to the mitral valve. The device reshapes the mitral valve to reduce leakage and regurgitation. Cardiac Dimensions aims to produce similar devices to treat other structural problems of heart valves.

Register To Buy and Sell Shares

For more details on financing and valuation for Cardiac Dimensions, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Cardiac Dimensions’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cardiac Dimensions.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Cardiac Dimensions investors also invested in these private companies


Management Team

Rick Wypych
President & Chief Executive Officer
Steven Goldberg, MD, FSCAI
Chief Medical Officer
Bob Calcote
Vice President, Operations & Compliance
Carmelo Mastrandrea
Vice President, Sales
Angie Swenson
Vice President, Clinical
Guenter Haines
Vice Presdient, Therapy Development

Board Members

Renee Ryan
RefleXion Medical
Gregory D. Casciaro
Independent Advisor
Doug Fisher
InterWest Partners
Gerry Brunk, MBA
Lumira Ventures
Kurt Wheeler
Blackstone Life Sciences
Nathan Every
Frazier Healthcare Partners
Jim Fitzsimmons
Tissue Regeneration Systems
Fouad Azzam
Life Sciences Partners

Frequently Asked Questions About Cardiac Dimensions’ Stock

Can you buy Cardiac Dimensions’ stock?
Cardiac Dimensions is not publicly traded on NYSE or NASDAQ in the U.S. To buy Cardiac Dimensions’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Cardiac Dimensions’ stock?
Yes, you can sell stock of a private company like Cardiac Dimensions. Forge can help you sell your Cardiac Dimensions stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Cardiac Dimensions’ stock price?
Cardiac Dimensions is a privately held company and therefore does not have a public stock price. However, you may access Cardiac Dimensions’ private market stock price with Forge Data.
What is Cardiac Dimensions’ stock ticker symbol?
Cardiac Dimensions does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Cardiac Dimensions Raises $35 Million in Series D Financing
Funds Expected to Support Enrollment in U.S. Pivotal EMPOWER Trial and European Commercial Expansion for Carillon Mitral Contour System.
Updated on: May 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.